Kelix bio

Premium

Healthcare

09 May, 2024

Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal

Kelix Bio, an emerging markets-focused specialty generic biopharmaceutical company is looking to acquire five UAE-based pharma entities to further expand ......

Dilasha Seth

Mubadala acquiring Afro-Indian pharma platform in landmark PE exit for DPI, others

Healthcare

26 March, 2024

Mubadala acquiring Afro-Indian pharma platform in landmark PE exit for DPI, others

Abu Dhabi’s sovereign investor Mubadala Investment Company, which manages assets worth $276 billion in more than 50 countries, is set ......

Dilasha Seth

Kelix bio makes fifth strategic deal since acquisition by Mubadala

Healthcare

16 January, 2025

Kelix bio makes fifth strategic deal since acquisition by Mubadala

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal since its acquisition by Abu ......